Forte Biosciences, Inc. - COMMON STOCK (FBRX)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
12.4M
Number of holders
26
Total 13F shares, excl. options
4.28M
Shares change
+3.54M
Total reported value, excl. options
$97.1M
Value change
+$81.9M
Number of buys
14
Number of sells
-10
Price
$22.71

Significant Holders of Forte Biosciences, Inc. - COMMON STOCK (FBRX) as of Q4 2024

32 filings reported holding FBRX - Forte Biosciences, Inc. - COMMON STOCK as of Q4 2024.
Forte Biosciences, Inc. - COMMON STOCK (FBRX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4.28M shares of 12.4M outstanding shares and own 34.38% of the company stock.
Largest 10 shareholders include FRED ALGER MANAGEMENT, LLC (1.13M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (620K shares), Ikarian Capital, LLC (609K shares), ORBIMED ADVISORS LLC (600K shares), BVF INC/IL (594K shares), Cable Car Capital, LP (220K shares), Woodline Partners LP (204K shares), PERCEPTIVE ADVISORS LLC (95.7K shares), BOOTHBAY FUND MANAGEMENT, LLC (89.2K shares), and FARALLON CAPITAL MANAGEMENT LLC (35K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.